• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特拉特(Tratt.)果醋对非酒精性脂肪性肝病的调控机制

Regulation mechanism of Tratt. () fruit vinegar on non-alcoholic fatty liver disease.

作者信息

Wang Yu, Lang Rui, Li Lilang, Wen Yonglan, Gao Ming, Zhang Jie, Yang Juan, Li Qiji, Wang Li, Yang Xiaosheng, Wang Xiaolong, Xie Chunzhi

机构信息

State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang, China.

Natural Products Research Center of Guizhou Province, Guiyang, China.

出版信息

Front Nutr. 2025 Aug 12;12:1617931. doi: 10.3389/fnut.2025.1617931. eCollection 2025.

DOI:10.3389/fnut.2025.1617931
PMID:40873448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12378049/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by the excessive accumulation of lipids as a pathological feature. Previous studies have demonstrated that Rosa roxburghii Tratt. fruit vinegar (RFV) played an important role in intervening in obesity and related complications by regulating the intestinal microbiota in high-fat diet mice.

METHODS

This study investigated the mechanisms by which RFV improves NAFLD from multiple perspectives. Potential targets were predicted by network pharmacology and molecular docking analyses. Intestinal microbial communities were detected and analyzed using 16S rRNA gene sequencing technology. Liver metabolites were detected and analyzed using ultra high performance liquid chromatography quadrupole-exactive high field-X mass spectrometer (UHPLC-Q-Exactive HF-X) and Progenesis QI software. Hepatic protein expression levels were detected and quantified using Western blotting analysis and gray-value analysis, respectively.

RESULTS

The results indicated that, RFV could improve the diversity of intestinal microbiota in NAFLD mice, reduce the ratio of Firmicutes to Bacteroidetes (F/B), and reverse the relative abundance of differential bacteria genera related to lipid accumulation and energy metabolism. The intestinal microbiota was correlated with the levels of lipid metabolism and oxidative stress in the serum and liver of mice with NAFLD. The primary bacteria genera involved were . A total of 441 liver metabolites were identified in NAFLD mice and participating in 21 metabolic pathways. Glycerophospholipid metabolism may be an important pathway regulating NAFLD by RFV. Phosphatidylcholines (PC) and lysophosphatidylcholinergic (LPC) metabolites were significantly regulated by RFV and had significant correlation with differential microbiota. RFV may improve NAFLD by regulating lipid synthesis in the adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway. Western blotting analysis showed that, RFV could activate the AMPK phosphorylation, and reduce the expression of fatty acid synthase (FASN) and sterol regulatory element-binding protein 1 (SREBP-1c), resulting in the inhibition of fatty acids de novo synthesis and lipid accumulation.

CONCLUSION

As a functional food, RFV has been proven to be effective in improving NAFLD. The underlying mechanisms involve the modulation of the intestinal microbiota and metabolites balance, and regulation on lipid disorders through AMPK signaling pathway.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种以脂质过度蓄积为病理特征的慢性肝病。既往研究表明,刺梨果醋(RFV)通过调节高脂饮食小鼠的肠道微生物群,在干预肥胖及相关并发症方面发挥重要作用。

方法

本研究从多个角度探讨RFV改善NAFLD的机制。通过网络药理学和分子对接分析预测潜在靶点。采用16S rRNA基因测序技术检测和分析肠道微生物群落。使用超高效液相色谱四极杆-高分辨质谱仪(UHPLC-Q-Exactive HF-X)和Progenesis QI软件检测和分析肝脏代谢物。分别采用蛋白质印迹分析和灰度值分析检测和定量肝脏蛋白表达水平。

结果

结果表明,RFV可改善NAFLD小鼠肠道微生物群的多样性,降低厚壁菌门与拟杆菌门的比例(F/B),并逆转与脂质蓄积和能量代谢相关的差异细菌属的相对丰度。肠道微生物群与NAFLD小鼠血清和肝脏中的脂质代谢水平及氧化应激相关。主要涉及的细菌属为 。在NAFLD小鼠中共鉴定出441种肝脏代谢物,参与21条代谢途径。甘油磷脂代谢可能是RFV调节NAFLD的重要途径。RFV显著调节磷脂酰胆碱(PC)和溶血磷脂酰胆碱(LPC)代谢物,且与差异微生物群具有显著相关性。RFV可能通过调节腺苷酸活化蛋白激酶(AMPK)途径中的脂质合成来改善NAFLD。蛋白质印迹分析表明,RFV可激活AMPK磷酸化,并降低脂肪酸合酶(FASN)和固醇调节元件结合蛋白1(SREBP-1c)的表达,从而抑制脂肪酸的从头合成和脂质蓄积。

结论

作为一种功能性食品,RFV已被证明对改善NAFLD有效。其潜在机制包括调节肠道微生物群和代谢物平衡,以及通过AMPK信号通路调节脂质紊乱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/69b78afb7eb4/fnut-12-1617931-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/471011997530/fnut-12-1617931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/a67afaf63e94/fnut-12-1617931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/76abdab72e73/fnut-12-1617931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/5de9702faabc/fnut-12-1617931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/da0ff918ca1e/fnut-12-1617931-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/366f2382460c/fnut-12-1617931-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/69b78afb7eb4/fnut-12-1617931-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/471011997530/fnut-12-1617931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/a67afaf63e94/fnut-12-1617931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/76abdab72e73/fnut-12-1617931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/5de9702faabc/fnut-12-1617931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/da0ff918ca1e/fnut-12-1617931-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/366f2382460c/fnut-12-1617931-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ad/12378049/69b78afb7eb4/fnut-12-1617931-g007.jpg

相似文献

1
Regulation mechanism of Tratt. () fruit vinegar on non-alcoholic fatty liver disease.特拉特(Tratt.)果醋对非酒精性脂肪性肝病的调控机制
Front Nutr. 2025 Aug 12;12:1617931. doi: 10.3389/fnut.2025.1617931. eCollection 2025.
2
Rhein alleviates hepatic steatosis in NAFLD mice by activating the AMPK/ACC/SREBP1 pathway to enhance lipid metabolism.大黄酸通过激活AMPK/ACC/SREBP1通路增强脂质代谢,从而减轻非酒精性脂肪性肝病(NAFLD)小鼠的肝脂肪变性。
Mol Med. 2025 Jul 10;31(1):255. doi: 10.1186/s10020-025-01304-4.
3
Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1/AMPK pathway.黄连温胆汤通过调节肠道微生物群介导的代谢重编程和激活LKB1/AMPK途径改善非酒精性脂肪性肝病的机制
PLoS One. 2025 Sep 2;20(9):e0331303. doi: 10.1371/journal.pone.0331303. eCollection 2025.
4
[Effect of Wenpi Pills on lipid metabolism in mice with non-alcoholic fatty liver disease induced by various diets].[温脾丸对不同饮食诱导的非酒精性脂肪肝小鼠脂质代谢的影响]
Zhongguo Zhong Yao Za Zhi. 2025 May;50(10):2730-2739. doi: 10.19540/j.cnki.cjcmm.20250120.401.
5
Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders.泽泻醇B通过调节嘌呤代谢和恢复肠道微生物群紊乱改善代谢功能障碍相关脂肪性肝病。
Phytomedicine. 2025 Jun 22;145:156992. doi: 10.1016/j.phymed.2025.156992.
6
Unravelling the mechanisms of erchen decoction in the treatment of nonalcoholic fatty liver disease (NAFLD): an integrative study combining network pharmacology, molecular docking, molecular dynamics simulation, multi-omics analysis, and experimental validation.解析二陈汤治疗非酒精性脂肪性肝病(NAFLD)的机制:一项结合网络药理学、分子对接、分子动力学模拟、多组学分析和实验验证的综合研究
J Ethnopharmacol. 2025 Jul 2;353(Pt A):120216. doi: 10.1016/j.jep.2025.120216.
7
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.樟芝及其复合成分去氢表雄酮酸通过上调 ALDH2 活性来减轻非酒精性脂肪肝疾病。
J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16.
8
Herbal mixture of Platycodon grandiflorum, Cinnamomum cassia, and Asiasarum sieboldii extracts protects against NASH progression via regulation of hepatic steatosis, inflammation, and apoptosis.桔梗、肉桂和细辛提取物的草药混合物通过调节肝脏脂肪变性、炎症和细胞凋亡来预防非酒精性脂肪性肝炎的进展。
Phytomedicine. 2025 Jul 14;145:157077. doi: 10.1016/j.phymed.2025.157077.
9
Network pharmacology and transcriptomics reveal complanatoside A regulates lipid metabolism in hyperlipidemia and nonalcoholic fatty liver disease via the AMPK pathway.网络药理学和转录组学揭示了扁蓄苷A通过AMPK途径调节高脂血症和非酒精性脂肪性肝病中的脂质代谢。
J Nutr Biochem. 2025 Oct;144:109960. doi: 10.1016/j.jnutbio.2025.109960. Epub 2025 May 10.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Ginseng and its functional components in non-alcoholic fatty liver disease: therapeutic effects and multi-target pharmacological mechanisms.人参及其功能成分在非酒精性脂肪性肝病中的治疗作用及多靶点药理机制
Front Pharmacol. 2025 Apr 9;16:1540255. doi: 10.3389/fphar.2025.1540255. eCollection 2025.
2
L-Theanine Mitigates Acute Alcoholic Intestinal Injury by Activating the HIF-1 Signaling Pathway to Regulate the TLR4/NF-κB/HIF-1α Axis in Mice.L-茶氨酸通过激活低氧诱导因子-1信号通路调节小鼠TLR4/NF-κB/HIF-1α轴减轻急性酒精性肠损伤
Nutrients. 2025 Feb 18;17(4):720. doi: 10.3390/nu17040720.
3
The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study.
槲皮素对非酒精性脂肪性肝病(NAFLD)的影响及自噬相关蛋白Beclin1、P62和LC3的作用:一项实验研究
Nutrients. 2024 Dec 11;16(24):4282. doi: 10.3390/nu16244282.
4
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).肠道微生物组和肥胖对癌症的发生、发展和预防的影响(综述)。
Int J Oncol. 2024 Jan;64(1). doi: 10.3892/ijo.2023.5592. Epub 2023 Nov 24.
5
Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics.八折汤运用整合脂质组学、网络药理学和药代动力学改善非酒精性脂肪性肝病的脂质功能障碍。
J Pharm Anal. 2023 Sep;13(9):1058-1069. doi: 10.1016/j.jpha.2023.05.012. Epub 2023 May 24.
6
Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE/HMGB-1 signaling pathway.青蒿素通过调节 AGE-RAGE/HMGB-1 信号通路减轻大鼠 2 型糖尿病性心肌病。
Sci Rep. 2023 Jul 8;13(1):11043. doi: 10.1038/s41598-023-37678-w.
7
Exploring the mechanism of browning of Rosa roxburghii juice based on nontargeted metabolomics.基于非靶向代谢组学探究刺梨汁褐变机制。
J Food Sci. 2023 May;88(5):1835-1848. doi: 10.1111/1750-3841.16534. Epub 2023 Mar 20.
8
Recent Advances on Main Active Ingredients, Pharmacological Activities of and Its Development and Utilization.及其主要活性成分、药理活性、开发与利用的研究进展 。 你提供的原文似乎不完整,句子表述不太清晰准确,我翻译的可能不完全符合其确切原意,你可以补充更完整准确的内容以便我能更好地翻译。
Foods. 2023 Mar 1;12(5):1051. doi: 10.3390/foods12051051.
9
Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.植物化学鞣花酸通过双重调节脂质代谢和线粒体功能,通过 AMPK-ACC-PPARa 轴缓解非酒精性脂肪性肝病。
Phytomedicine. 2023 Jan;109:154589. doi: 10.1016/j.phymed.2022.154589. Epub 2022 Dec 10.
10
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.非酒精性脂肪性肝病(NAFLD)发病机制及天然产物的防治。
Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489.